Fortis Healthcare has posted a net loss of ₹22.28 crore for the quarter ended December 31 against a net profit of ₹389.1 crore during the corresponding quarter of the previous fiscal.
However, the company, which is in the process of exiting all its international assets, posted an increase in total income to ₹1,024.53 crore during the third quarter, from ₹1,018.72 crore.
During the quarter, the company gained ₹424.16 crore after Fortis diluted its shares in Hong Kong’s Quality Healthcare.
This is one of the reasons for the wide difference. In keeping with its move away from international businesses, Fortis is expected to complete the sale of RadLink-Asia Pte Ltd by the first quarter of the coming fiscal, Shivinder Mohan Singh, Executive Vice-Chairman, Fortis Healthcare, said.
The company had announced the sale, worth more than ₹655 crore, in September 2014.
The company has also put another hospital in Singapore — Fortis Surgical Hospital — on the block as it’s planning to exit that asset, too, Singh said during a call.
On Friday, Fortis Healthcare’s scrip closed at ₹138.95 on BSE, up 1.13 per cent, while the benchmark Sensex gained 1.01 per cent to 29,094.93 points.